Akebia Therapeutics (AKBA) Total Debt Growth (3y) (2021 - 2026)
Akebia Therapeutics (AKBA) Total Debt Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -7.03% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.29% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -58.89% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -12.80% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 72.82% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -4.66% |
| 10 | Akebia Therapeutics | 243.23 Mn | 80.63 Mn | 41.25 Mn | -0.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.94% |
| Dec 31, 2025 | -9.95% |
| Sep 30, 2025 | -10.27% |
| Jun 30, 2025 | -21.73% |
| Mar 31, 2025 | -21.96% |
| Dec 31, 2024 | -26.52% |
| Sep 30, 2024 | -26.66% |
| Jun 30, 2024 | -26.79% |
| Mar 31, 2024 | -32.17% |
| Dec 31, 2023 | -28.87% |
| Sep 30, 2023 | -17.76% |
| Jun 30, 2023 | -17.74% |
| Mar 31, 2023 | -12.88% |
| Dec 31, 2022 | -4.47% |
| Dec 31, 2021 | 86.65% |